Back to search
FDAFDA · Food and drugs·Recall number Z-2085-2013

HSV 2 Primers, Catalog #18081020. Analyte Specific Reagent. The HSV-2 primer pair is specific for HSV-2 (Herpes Simplex Virus 2). For use in Clinical laboratories when developing their own diagnostic tests.

Published September 4, 2013 · Recall initiated: May 13, 2013

Summary

FDA records medical device Class II recall Z-2085-2013, published September 4, 2013 and initiated May 13, 2013. Recalling firm: Life Technologies Corporation; Status: Terminated; Reported quantity: 15 kits; Lot: Catalog #18081020, Lot #1368760 & Lot #1312093. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Firm received complaints that HSV-2 primers failed to amplify HSV-2 DNA.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Life Technologies Corporation
Distributor
USA Nationwide Distribution in the states of DE, IA, MN, and NC.
Lot
Catalog #18081020, Lot #1368760 & Lot #1312093
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was HSV 2 Primers, Catalog #18081020. Analyte Specific Reagent. The HSV-2 primer pair is specific for HSV-2 (Herpes Simplex Virus 2). For use in Clinical laboratories when developing their own diagnostic tests. recalled?

Yes. FDA published recall Z-2085-2013 on September 4, 2013. Reported hazard: Firm received complaints that HSV-2 primers failed to amplify HSV-2 DNA.

What should I do if I have this product?

Voluntary: Firm initiated · Letter